In this issue:
Rocatinlimab for moderate-to-severe AD
Associations of mortality with pyoderma gangrenosum
Hyperkeratotic flexural erythema after benzalkonium chloride exposure
Apremilast for off-label dermatological disorders
Lebrikizumab + topical steroids for moderate-to-severe AD
Risk factors of progression from DLE to severe SLE
Association between early-life antibiotic use and early childhood AD
Diphencyprone immunotherapy clears palmoplantar warts
Topical sirolimus for facial angiofibromas in tuberous sclerosis complex
Standardised emollient regimen for preventing AD in at-risk infants
Please login below to download this issue (PDF)